689 results on '"A. Lavolé"'
Search Results
2. Fine mapping of RNA isoform diversity using an innovative targeted long-read RNA sequencing protocol with novel dedicated bioinformatics pipeline
3. OA3-2 PD-1 blockade in 12 HIV-infected patients with lung cancer
4. Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
5. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART, IFCT 0503): an open-label, randomised, phase 3 trial
6. Parcours de diagnostic rapide du cancer du poumon : évaluation à un an
7. Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial
8. Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA)
9. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)
10. Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non–small cell lung cancer: IFCT-1201 MODEL trial
11. Ongoing challenges of using immunotherapy in special populations: Poor performance status patients, elderly patients, and people living with HIV
12. Les nouveaux traitements des maladies inflammatoires chroniques de l’intestin
13. Development and Validation of a Simplified Prognostic Score in SCLC
14. Comment réduire la mortalité par cancer du poumon chez les personnes vivant avec le VIH ? Du sevrage tabagique au dépistage radiologique
15. Syndrome de LYNCH : identification et prise en charge
16. Is chemotherapy rechallenge feasible in advanced-stage non-small-cell lung cancer?
17. VIH et impact sur le choix thérapeutique
18. FrOG – The French OncoGenetics database
19. Infections virales chroniques (hépatites, VIH) et impact sur le choix thérapeutique
20. Évaluation, prévention et gestion des toxicités de la chimiothérapie, des anti-angiogéniques et de l’immunothérapie
21. Prise en charge thérapeutique des cancers bronchiques non à petites cellules de stades avancés mutés pour l’EGFR
22. Les traitements péri-opératoires des cancers bronchiques non à petites cellules : standards actuels et perspectives
23. Impact de l’amélioration de la filière diagnostique sur le pronostic
24. Cancer et VIH : actualités 2017
25. Le cancer bronchopulmonaire chez les patients infectés par le VIH
26. Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
27. Les essais cliniques en oncologie thoracique à l’ère de la médecine de précision : comment les réaliser en pratique ?
28. Altérations moléculaires anciennes et émergentes : quand les rechercher ?
29. Crizotinib chez les patients atteints de cancer bronchopulmonaire ROS1 positifs
30. Place des traitements complémentaires pour les cancers bronchiques non à petites cellules opérables non N2
31. Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group
32. Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Carcinoma
33. Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group
34. Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC – IFCT 02-01
35. Actualités sur les thérapies ciblées dans les cancers bronchiques non à petites cellules, hors immunothérapie
36. Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition
37. Le cancer broncho-pulmonaire : les patients immunodéprimés: Lung cancer in immunodeficient patients
38. Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience
39. Cancer bronchique et inflammation
40. Cancer bronchopulmonaire dans la population des patients vivant avec le VIH
41. Optimiser le bilan d'extension locorégional
42. Comment offrir à tous un accès aux thérapeutiques innovantes ?
43. Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature Review
44. Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)
45. Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial
46. VIH et Cancer: état Des Connaissances
47. Place des traitements complémentaires pour les CBNPC opérables
48. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung
49. Mise au point 2014 du cancer bronchique non à petites cellules (en dehors du dépistage)
50. 2014 update on non-small cell lung cancer (excluding diagnosis)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.